Stocks Crossing 50-Day SMA 01/07: (INO) (OCN) (VRNG) Above; (ILMN) (LULU) (TSO) Below

• Inovio Pharmaceuticals, Inc. (AMEX: INO) - up 14.6 percent. Announced a follow-on collaboration with the PATH Malaria Vaccine Initiative to advance malaria vaccine development and new vaccination delivery technologies. Researchers will test whether a novel vaccine approach that combines genetically engineered DNA with an innovative vaccine delivery technology called electroporation could induce an immune response in humans that protects against malaria parasite infection.
  
  
• Ocwen Financian Corp (Nasdaq: OCN) - up 3.0 percent. Ocwen has been trapped in a range spanning from $34 to about $37 over the last few weeks, making today's positive move enough to get above the 50-day SMA.
  
  
• Vringo, Inc. (AMEX: VRNG) - up 1.5 percent. Trying to regain some ground after dipping 5 percent last Friday. The stock had broken out of a downward channel recently, but has gained enough gusto to get back above the $4 level. The 14-day Money Flow Index is toward the upper-end of its range, currently reading about 70.6 or so. The 80 level is a rough estimate for being overbought.

• Illumina, Inc. (Nasdaq: ILMN) - down 7.2 percent. Entered a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone payments through 2015. Roche (OTCBB: RHHBY) CEO Humer said a potential deal won't happen now.
  
  
• lululemon athletica, Inc. (Nasdaq: LULU) - down 2.0 percent. Filed a common stock shelf registration today, with CEO Wilson filing to sell 5.7 million shares.
  
  
• Tesoro Corp. (NYSE: TSO) - down 1.0 percent. Filed two 8-Ks with the U.S. SEC today detailing amended credit agreements recently inked. For more color, click here.

You May Also Be Interested In

• After-hours movers: United Airlines, J.B. Hunt, and more
• Kartoon Studios (TOON) Prices 7M Share Offering at $1/sh
• TG Therapeutics (TGTX) Announces Additional Data Presentations for BRIUMVI in Multiple Sclerosis